This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange gained 1.67 points to close at 524.14 Wednesday. Norman Eyolfson's third capital pool shell, CT Developers Ltd. (DEV: halted), is still working on the potential qualifying transaction that it first announced in November, 2017. The potential QT is a blockchain deal, which would have been trendy and promotable in November, 2017, but not so much in November, 2019. The shell's QT target, Clinical Blockchain Data Sciences Inc., has changed its name to CBDS Health Inc.

CBDS Health has a software platform for managing clinical trials. The platform uses blockchain technology, but this was not always the case. The platform was first developed in 2004 by an affiliate of the Oregon Health & Science University. As of November, 2017, the platform had been used on 60 studies involving 1,000 patients, and it had collected one million hours of continuous patient-monitoring data. (It collects data in real time through sensors worn by patients.)

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS